Cardiac Rehab for Functional Improvement.

Current Heart Failure Reports
Elizabeth EpsteinPam R Taub

Abstract

Cardiac Rehabilitation (CR) was originally designed to return patients to their prior level of functioning after myocardial infarction (MI). Research has since revealed the mortality benefit of CR, and CR has been given a class 1A recommendation by the American Heart Association/American College of Cardiology (AHA/ACC). In this review, we shift our focus back to function and highlight the most recent research on the functional benefits of CR in a broad range of cardiac diseases and conditions. Currently, CR is indicated for patients with coronary artery disease (CAD), heart failure with reduced ejection fraction (HFrEF), peripheral arterial disease (PAD), transcatheter aortic valve replacement (TAVR), left ventricular assist devices (LVADs), and cardiac transplant. Among patients with those conditions, CR has been shown to improve exercise capacity, cognition, mental health, and overall quality of life. As survival of cardiac diseases increases, CR emerges as an increasingly important tool to lend quality to patients' lives and therefore give meaning to survival.

References

May 1, 1992·British Heart Journal·J HorganR Nagle
Nov 1, 1990·Chest·M D HammondR D Rocha
Sep 1, 1993·Journal of the American College of Cardiology·C J LavieA B Littman
Mar 1, 1993·Journal of the American College of Cardiology·F J Pashkow
Dec 1, 1996·Journal of the American College of Cardiology·J Niebauer, J P Cooke
Dec 1, 1996·Journal of Molecular and Cellular Cardiology·B A TikunovS Levine
Dec 24, 1998·JAMA : the Journal of the American Medical Association·D OrnishR J Brand
Apr 12, 2000·Circulation·A KollerG J Balady
Jun 13, 2002·Mayo Clinic Proceedings·Lisa M Benrud-LarsonPhillip A Low
Sep 24, 2002·The Journal of Biological Chemistry·Brett LangleyRavi Kambadur
May 18, 1957·Journal of the American Medical Association·H K HELLERSTEIN, A B FORD
Mar 17, 2004·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Steven M HollenbergMaria Rosa Costanzo
Jan 22, 2005·Journal of Hypertension·Hanspeter BrunnerUNKNOWN Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension
Mar 19, 2005·European Journal of Nuclear Medicine and Molecular Imaging·Kai KendziorraRegine Kluge
May 17, 2005·Journal of the American College of Cardiology·Christos Kasapis, Paul D Thompson
Oct 28, 2005·Essays in Biochemistry·Didier AttaixLydie Combaret
Dec 27, 2005·The American Journal of Cardiology·David P Swain, Barry A Franklin
Oct 17, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Catherine CoiraultYves Lecarpentier
May 10, 2007·Clinical Transplantation·Gaye UlubayMehmet Haberal
Jun 27, 2007·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·H KarapolatS Karakula
May 23, 2008·Journal of Cardiopulmonary Rehabilitation and Prevention·Marie C AudelinPhilip A Ades
Oct 16, 2008·Current Vascular Pharmacology·Michel R HoenigFrank W Sellke
Nov 11, 2008·Biochimica Et Biophysica Acta·A J MurtonP L Greenhaff
Apr 9, 2009·JAMA : the Journal of the American Medical Association·Kathryn E FlynnUNKNOWN HF-ACTION Investigators
Apr 10, 2009·American Journal of Physiology. Cell Physiology·Anne Ulrike TrendelenburgDavid J Glass
Jun 15, 2010·Circulation. Heart Failure·Barry A BorlaugMargaret M Redfield
Nov 26, 2010·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·M Melyn GalbreathBenjamin D Levine
Dec 15, 2010·The American Journal of Cardiology·Richard V MilaniHector O Ventura
Apr 1, 2011·European Journal of Preventive Cardiology·Karsten LenkVolker Adams
Aug 16, 2011·Transplantation Proceedings·F BuendíaA Salvador
Sep 29, 2011·Journal of Aging and Physical Activity·Antonia M Martin, Catherin B Woods
Nov 19, 2011·Cardiology·Ping-Lun HsiehWan-Ju Chao

❮ Previous
Next ❯

Citations

Sep 3, 2020·Current Heart Failure Reports·Savitri Fedson
Apr 15, 2021·Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace·Chiara PenatiOreste Carlo Febo
Aug 17, 2021·Current Opinion in Cardiology·Elizabeth EpsteinPam R Taub

❮ Previous
Next ❯

Related Concepts

Related Feeds

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.

Related Papers

Journal of the American College of Cardiology
Daniel E FormanAmerican College of Cardiology’s Prevention of Cardiovascular Disease Section
Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health
Karam I Turk-AdawiSherry L Grace
© 2022 Meta ULC. All rights reserved